US693094A
(en)
|
1900-08-13 |
1902-02-11 |
Hall Signal Co |
Signal and signaling-circuit.
|
US2457820A
(en)
|
1945-12-27 |
1949-01-04 |
Merck & Co Inc |
Amino acid solution and process for preparing the same
|
US3012926A
(en)
|
1957-10-17 |
1961-12-12 |
Arvin Ind Inc |
Method of making quilted padded articles
|
GB1034358A
(en)
|
1963-05-01 |
1966-06-29 |
Chugai Pharmaceutical Co Ltd |
Body-protein-biosynthesis promoting composition
|
JPS5133B1
(es)
|
1969-07-25 |
1976-01-05 |
|
|
US3832465A
(en)
|
1971-12-09 |
1974-08-27 |
H Ghadimi |
Injectable amino acid composition commensurate to the anabolic need of the body and method of using same
|
US3988466A
(en)
|
1973-06-01 |
1976-10-26 |
Kyowa Hakko Kogyo Co., Ltd. |
Prevention of gastric lesions
|
US3950529A
(en)
|
1975-02-03 |
1976-04-13 |
Massachusetts General Hospital |
Amino acid formulations for patients with liver disease and method of using same
|
JPS52108031A
(en)
|
1976-03-04 |
1977-09-10 |
Masahiro Takizawa |
Method of preparation of tooth paste
|
JPS5470158A
(en)
|
1977-11-14 |
1979-06-05 |
Nhk Spring Co Ltd |
Cushion and making method thereof
|
JPS5535049A
(en)
|
1978-09-04 |
1980-03-11 |
Otsuka Pharmaceut Factory Inc |
Amino acid transfusion for cancerous patient
|
DE2906034C2
(de)
|
1979-02-16 |
1985-03-28 |
Maggi AG, Kempttal |
Verfahren zur Gewinnung von L-Leucin, L-Phenylalanin, L-Tyrosin, L-Cystin und von Gemischen aus L-Leucin und L-Isoleucin
|
CA1184499A
(en)
|
1981-06-29 |
1985-03-26 |
David C. Madsen |
Nutritional composition for management of hepatic failure
|
US4898879A
(en)
|
1981-06-29 |
1990-02-06 |
Baxter International Inc. |
Nurtitional composition for management of hepatic failure
|
JPS58126767A
(ja)
|
1982-01-22 |
1983-07-28 |
Ajinomoto Co Inc |
肝臓病患者用栄養組成物
|
US5298493A
(en)
|
1983-04-20 |
1994-03-29 |
Clintec Nutrition Co. |
Compound for use in dietetics, reanimation and therapeutics containing protein fractions based on three types of minipeptides
|
CH658165A5
(fr)
|
1984-01-04 |
1986-10-31 |
Nestle Sa |
Produit alimentaire efficace dans le traitement de la lepre.
|
US5034377A
(en)
|
1984-11-19 |
1991-07-23 |
Montefiore Hospital Association Of Western Pennsylvania |
Aqueous nutrient compositions comprising oligopeptides
|
US4871550A
(en)
|
1986-09-05 |
1989-10-03 |
Millman Phillip L |
Nutrient composition for athletes and method of making and using the same
|
FR2618331B1
(fr)
|
1987-07-23 |
1991-10-04 |
Synthelabo |
Compositions pharmaceutiques utiles pour le traitement de l'uremie
|
US5028622A
(en)
|
1988-05-06 |
1991-07-02 |
Ajinomoto Company, Inc. |
Administration of amino acids as treatment for neurodegenerative disorders
|
US5576351A
(en)
|
1989-12-29 |
1996-11-19 |
Mcgaw, Inc. |
Use of arginine as an immunostimulator
|
ATE110531T1
(de)
|
1990-11-01 |
1994-09-15 |
Sandoz Nutrition Ltd |
Hochsaures system enthaltende nahrungsformulierungen.
|
US5106836A
(en)
|
1991-02-22 |
1992-04-21 |
Clintec Nutrition Co. |
Enteral diet
|
US5977073A
(en)
|
1991-06-06 |
1999-11-02 |
Life Sciences' Technologies, Inc. |
Nutrient composition for treatment of immune disorders
|
US5780039A
(en)
|
1992-04-23 |
1998-07-14 |
Novartis Nutrition Ag |
Orally-ingestible nutrition compositions having improved palatability
|
US5229136A
(en)
|
1992-05-21 |
1993-07-20 |
Clintec Nutrition Co. |
Low caloric density enteral formulation designed to reduce diarrhea in tube-fed patients
|
US5276018A
(en)
|
1992-07-17 |
1994-01-04 |
Brigham And Women's Hospital |
Composition comprising amino acids and methods for decreasing muscle breakdown
|
DE4229166A1
(de)
|
1992-09-01 |
1994-03-03 |
Deutsches Krebsforsch |
Mittel zur Aufrechterhaltung und/oder Steigerung der Muskelleistung und Körperzellmasse
|
US5356873A
(en)
|
1992-11-05 |
1994-10-18 |
Clintec Nutrition Co. |
Method for providing nutritional requirements to patients having a chronic inflammation reaction
|
AU679020B2
(en)
|
1992-12-23 |
1997-06-19 |
Abbott Laboratories |
Medical foods for the nutritional support of infant/toddler metabolic diseases
|
US5348979A
(en)
|
1992-12-23 |
1994-09-20 |
Iowa State University Research Foundation Inc. |
Method of promoting nitrogen retention in humans
|
US5571783A
(en)
|
1993-03-09 |
1996-11-05 |
Clintec Nutrition Company |
Composition and method for treating patients with hepatic disease
|
US5891459A
(en)
|
1993-06-11 |
1999-04-06 |
The Board Of Trustees Of The Leland Stanford Junior University |
Enhancement of vascular function by modulation of endogenous nitric oxide production or activity
|
US5712309A
(en)
|
1993-08-10 |
1998-01-27 |
Musashi Pty Ltd. |
Composition for treatment of hangovers
|
US5438042B1
(en)
|
1993-10-08 |
1997-08-26 |
Sandoz Nutrition Ltd |
Enteral nutritional composition having amino acid profile
|
AU682894B2
(en)
|
1993-10-28 |
1997-10-23 |
Institut National De La Recherche Agronomique |
Composition based on amino acids intended for the treatment of sepsis or of an attack bringing about an inflammatory reaction, in animals and man
|
US5378722A
(en)
|
1993-12-03 |
1995-01-03 |
Clintec Nutrition Co. |
Nutritional compositions for management of nitrogen metabolism
|
US5723446A
(en)
|
1993-12-23 |
1998-03-03 |
Nestec Ltd. |
Enteral formulation designed for optimized nutrient absorption and wound healing
|
US5714472A
(en)
|
1993-12-23 |
1998-02-03 |
Nestec Ltd. |
Enternal formulation designed for optimized nutrient absorption and wound healing
|
GB9403935D0
(en)
|
1994-03-01 |
1994-04-20 |
Sandoz Nutrition Ltd |
Improvements in or relating to organic compounds
|
US5719133A
(en)
|
1994-09-21 |
1998-02-17 |
Novartis Nutrition Ag |
Adolescent dietary composition
|
IT1275434B
(it)
|
1995-05-19 |
1997-08-07 |
Farmila Farma Milano |
Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
|
US5728678A
(en)
|
1995-06-06 |
1998-03-17 |
Nestec Ltd. |
Method and composition for providing nutrition to a renal failure patient
|
US5733884A
(en)
|
1995-11-07 |
1998-03-31 |
Nestec Ltd. |
Enteral formulation designed for optimized wound healing
|
US6087398A
(en)
|
1996-03-01 |
2000-07-11 |
South Alabama Medical Science Foundation |
Sickle cell anemia treatment
|
US5716926A
(en)
|
1996-07-26 |
1998-02-10 |
Paxton K. Beale |
Composition of pyruvate and protein and method for increasing protein concentration in a mammal
|
US6096785A
(en)
|
1996-07-30 |
2000-08-01 |
Novartis Nutrition Ag |
Amino acid compositions and use thereof in treating renal dysfunction
|
JPH1053521A
(ja)
|
1996-08-12 |
1998-02-24 |
Kagaku Gijutsu Shinko Jigyodan |
脳内グルタミン酸の活性抑制剤および活性増強剤
|
IT1289754B1
(it)
|
1996-12-16 |
1998-10-16 |
Professional Dietetics Srl |
Composizioni a base di aminoacidi
|
US6013273A
(en)
|
1997-01-27 |
2000-01-11 |
Novartis Nutrition Ag |
Treatment of endotoxic shock
|
US5817329A
(en)
|
1997-02-28 |
1998-10-06 |
Gardiner; Paul T. |
Nutritional supplement for increased muscle size and strength for body builders
|
US5849335A
(en)
|
1997-06-02 |
1998-12-15 |
Nestec S.A. |
Composition and method for providing glutamine
|
AU7764798A
(en)
|
1997-06-02 |
1998-12-21 |
Societe Des Produits Nestle S.A. |
Product and method for providing glutamine
|
US6281244B1
(en)
|
1997-06-05 |
2001-08-28 |
Novartis Nutrition Ag |
Therapeutic use for glycine
|
CA2239582C
(en)
|
1997-06-05 |
2008-04-22 |
Novartis Nutrition Ag |
A new therapeutic use for glycine
|
EP0891719A1
(en)
|
1997-07-14 |
1999-01-20 |
N.V. Nutricia |
Nutritional composition containing methionine
|
IT1294227B1
(it)
|
1997-08-01 |
1999-03-24 |
Sigma Tau Ind Farmaceuti |
Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
|
TW473387B
(en)
|
1997-09-30 |
2002-01-21 |
Chugai Pharmaceutical Co Ltd |
Pharmaceutical or food compositions for treating hepatic diseases or improving liver functions
|
US6288116B1
(en)
|
1998-05-13 |
2001-09-11 |
Novartis Nutrition Ag |
Method of administration of a nutritional product to a person having renal failure
|
US6203820B1
(en)
|
1998-05-28 |
2001-03-20 |
Brice E. Vickery |
Compositions and methods for enhancing protein anabolism and detoxification
|
US6103748A
(en)
|
1998-06-19 |
2000-08-15 |
Bryan; Thomas B. |
Method of treating an autoimmune disorder
|
US6031000A
(en)
|
1998-06-23 |
2000-02-29 |
Iowa State University Research Foundation, Inc. |
Composition comprising β-hydroxy-β-methylbutyric acid and at least one amino acid and methods of use
|
JP2000072669A
(ja)
|
1998-08-24 |
2000-03-07 |
Inst Of Physical & Chemical Res |
アミノ酸・糖組成物
|
US6458338B1
(en)
|
1998-09-22 |
2002-10-01 |
Aeropharm Technology Incorporated |
Amino acid stabilized medicinal aerosol formulations
|
US20010041187A1
(en)
|
1998-10-20 |
2001-11-15 |
Carl W Hastings |
Performance-enhancing dietary supplement
|
EP1004302A3
(en)
|
1998-10-29 |
2003-06-04 |
Ajinomoto Co., Inc. |
Immunomodulator
|
US6051236A
(en)
|
1998-11-12 |
2000-04-18 |
Pacifichealth Laboratories, Inc. |
Composition for optimizing muscle performance during exercise
|
US6143786A
(en)
|
1999-02-02 |
2000-11-07 |
Novartis Nutrition Ag |
Oral arginine and insulin secretion
|
US6241996B1
(en)
|
1999-04-09 |
2001-06-05 |
Novartis Nutrition Ag |
Liquid soy nutritional products
|
CA2306720A1
(en)
|
1999-04-27 |
2000-10-27 |
Philip White |
Supplement for restoring growth hormone levels
|
WO2001026642A2
(en)
|
1999-10-08 |
2001-04-19 |
Joyce Corinne Bechthold |
Methods and compositions for treating neurobehavioral disorders
|
GB9929497D0
(en)
|
1999-12-14 |
2000-02-09 |
Vitaflo Limited |
Improved amino acid mixtures for the treatment and/or management of certain diseases
|
MXPA02007466A
(es)
|
2000-02-01 |
2004-02-26 |
Muscletech Res And Dev Inc |
Suplemento alimenticio a base de acido alfa-lipoico para incrementar la masa muscular escas y la fuerza.
|
US6833350B2
(en)
|
2000-02-04 |
2004-12-21 |
Nestec S.A. |
Method for maintaining or improving the synthesis of mucins
|
US6521591B1
(en)
|
2000-02-10 |
2003-02-18 |
N.V. Nutricia |
Pharmaceutical composition for muscular anabolism
|
GB0009056D0
(en)
|
2000-04-12 |
2000-05-31 |
Nestle Sa |
Composition comprising free amino acids
|
WO2001078533A2
(en)
|
2000-04-18 |
2001-10-25 |
Société des Produits Nestlé S.A. |
Nutritional modules
|
US6391332B1
(en)
|
2000-04-20 |
2002-05-21 |
Baxter International, Inc. |
Therapeutic micronutrient composition for severe trauma, burns and critical illness
|
IT1320782B1
(it)
|
2000-07-04 |
2003-12-10 |
Professional Dietetics Srl |
Composizioni a base di aminoacidi, atte al trattamentodell'insufficienza cardiaca.
|
US20030187049A1
(en)
|
2000-07-04 |
2003-10-02 |
Dioguardi Francesco Saverio |
Compositions based on aminoacids, suitable for improving muscle performance
|
IT1320783B1
(it)
|
2000-07-04 |
2003-12-10 |
Professional Dietetics Srl |
Composizioni a base di aminoacidi, atte al miglioramento delleprestazioni muscolari.
|
US6864242B2
(en)
|
2001-03-05 |
2005-03-08 |
Stephen P. Ernest |
Enteral formulation
|
DE60233558D1
(de)
|
2001-03-15 |
2009-10-15 |
Takashi Abe |
Aminosäurezusammensetzungen zur linderung einer fehlfunktion der leber
|
US20020193342A1
(en)
|
2001-05-09 |
2002-12-19 |
Hamman John P. |
Modifying undesirable tastes
|
ITTO20010580A1
(it)
|
2001-06-15 |
2002-12-15 |
Professional Dietetics Srl |
Composizioni a base di aminoacidi per il miglioramento della funzioneventricolare miocardica in pazienti affetti da diabete.
|
US6864230B2
(en)
|
2001-07-31 |
2005-03-08 |
Novartis Nutrition Ag |
Glutamine rich dietary composition
|
EP1466602A4
(en)
|
2001-12-25 |
2006-03-01 |
Ajinomoto Kk |
ORGAN FIBROSIS INHIBITORS
|
WO2003061639A2
(en)
|
2002-01-25 |
2003-07-31 |
Diamedica Inc. |
Use of glutathione synthesis stimulating compounds in reducing insulin resistance
|
JP2003238401A
(ja)
|
2002-02-20 |
2003-08-27 |
Ajinomoto Co Inc |
疾患の治療、改善又は予防用医薬品及び飲食品
|
US20050176827A1
(en)
|
2002-05-10 |
2005-08-11 |
Lee Steve S. |
Compositions and methods for glycogen synthesis
|
US7338675B2
(en)
|
2002-05-10 |
2008-03-04 |
Tsi Health Sciences, Inc. |
Fenugreek seed bio-active compositions and methods for extracting same
|
EP1549299B1
(en)
|
2002-06-05 |
2014-08-20 |
IVAX Pharmaceuticals s.r.o. |
Reduction of gelatin cross-linking
|
AU2003261825A1
(en)
|
2002-08-30 |
2004-03-19 |
Ajinomoto Co., Inc. |
Therapeutic agent for hepatic disease
|
US20040087490A1
(en)
|
2002-09-20 |
2004-05-06 |
Troup John P. |
Nutritional compositions
|
US20040057983A1
(en)
|
2002-09-25 |
2004-03-25 |
David Schmidt |
Biomolecular wearable apparatus
|
US7037522B2
(en)
|
2002-09-27 |
2006-05-02 |
Western Holdings, L.L.C. |
Nocturnal muscle enhancing composition and method
|
JP2004123564A
(ja)
|
2002-09-30 |
2004-04-22 |
Inst Of Physical & Chemical Res |
中枢機能改善用アミノ酸組成物
|
JP2004182705A
(ja)
|
2002-10-11 |
2004-07-02 |
Yasutoshi Koga |
ミトコンドリア機能異常に起因する疾患における臨床症状発現の予防・治療用組成物
|
US7547450B2
(en)
|
2002-10-24 |
2009-06-16 |
Nestec Ltd. |
Senior feline food
|
US8093292B2
(en)
|
2002-11-22 |
2012-01-10 |
Bionexus, Ltd. |
Methods for the treatment of HIV-1 related fat maldistribution, fasting hyperlipidemia and modification of adipocyte physiology
|
US7288570B2
(en)
|
2002-12-20 |
2007-10-30 |
Nutricia N.V. |
Stimulation of in vivo production of proteins
|
US20040120983A1
(en)
|
2002-12-23 |
2004-06-24 |
Philip Connolly |
Nutritional supplement
|
CN1329030C
(zh)
|
2002-12-26 |
2007-08-01 |
味之素株式会社 |
肝癌发生·发展抑制剂
|
JP4989836B2
(ja)
|
2002-12-26 |
2012-08-01 |
大塚製薬株式会社 |
経口栄養剤
|
EP1605781A1
(en)
|
2003-03-18 |
2005-12-21 |
Novartis AG |
Compositions comprising fatty acids and amino acids
|
US20040213838A1
(en)
|
2003-04-24 |
2004-10-28 |
Mazer Terrence B. |
Medical food tablets containing free amino acids
|
JP4528925B2
(ja)
|
2003-05-30 |
2010-08-25 |
独立行政法人理化学研究所 |
アミノ酸組成物及び補液
|
DK1638418T3
(da)
|
2003-06-23 |
2012-09-17 |
Nestec Sa |
Aminosyretilsætning til et sundt mikrobiota-økosystem
|
JP2005027524A
(ja)
|
2003-07-08 |
2005-02-03 |
Ajinomoto Co Inc |
経口アミノ酸組成物
|
US20050070607A1
(en)
|
2003-08-19 |
2005-03-31 |
James Andrus |
N-acetylcysteine compositions and methods for the treatment and prevention of cysteine/glutathione deficiency in diseases and conditions
|
ITTO20030789A1
(it)
|
2003-10-07 |
2005-04-08 |
Professional Dietetics Srl |
Composizione a base di amino acidi per il trattamento
|
CA2542652C
(en)
|
2003-10-16 |
2014-05-13 |
Nestec S.A. |
Nutritional composition against side effects of chemotherapy or radiotherapy
|
EP1685833A1
(en)
|
2003-11-21 |
2006-08-02 |
Ajinomoto Co., Inc. |
Remedy for diabetes
|
ES2550608T3
(es)
|
2003-12-20 |
2015-11-11 |
Nestec S.A. |
Composición nutritiva para la curación de las heridas
|
JPWO2005072721A1
(ja)
|
2004-01-28 |
2007-09-06 |
味の素株式会社 |
局所脳血流低下に伴う神経系障害の予防または治療のための医薬組成物
|
WO2005082163A1
(ja)
|
2004-02-27 |
2005-09-09 |
Incorporated Administrative Agency National Agriculture And Food Research Organization |
遊離アミノ酸を富化した食品素材及びその製造法
|
US20050233013A1
(en)
|
2004-03-02 |
2005-10-20 |
Lee Steve S |
Methods for enhancing the transport of glucose for balancing blood sugar levels
|
US20050215640A1
(en)
|
2004-03-26 |
2005-09-29 |
Baxter Jeffrey H |
HMB compositions and uses thereof
|
JP4815752B2
(ja)
|
2004-04-01 |
2011-11-16 |
味の素株式会社 |
アミノ酸含有飲食品
|
WO2005110124A1
(en)
|
2004-04-15 |
2005-11-24 |
Abbott Laboratories |
Composition and methods for nutritional management of patients with hepatic disease
|
CN1582912A
(zh)
|
2004-06-10 |
2005-02-23 |
武汉启瑞科技发展有限公司 |
L-鸟氨酸和 l-门冬氨酸组合物
|
WO2006009975A2
(en)
|
2004-06-22 |
2006-01-26 |
Maxim Pharmaceuticals, Inc. |
Histamine to treat disorders affecting muscle function
|
KR20120125993A
(ko)
|
2004-07-14 |
2012-11-19 |
아지노모토 가부시키가이샤 |
C형 간염 바이러스 양성 사람 간경변 환자용 간암 발생·진전 억제제
|
WO2006009437A2
(en)
|
2004-07-19 |
2006-01-26 |
N.V. Nutricia |
Use of aspartate for regulating glucose levels in blood
|
EP1637163A1
(en)
|
2004-09-21 |
2006-03-22 |
Andreas Kluge |
Indicator of therapeutic compliance
|
JP5177785B2
(ja)
|
2004-11-02 |
2013-04-10 |
味の素株式会社 |
周術期患者用薬剤
|
SI2319581T1
(sl)
|
2004-11-26 |
2015-10-30 |
Ucl Business Plc |
Pripravki, ki obsegajo ornitin in fenilacetat ali fenilbutirat za zdravljenje hepatične encefalopatije
|
US20090048153A1
(en)
|
2004-12-03 |
2009-02-19 |
University Of Maryland, Baltimore |
Composition for treating sulfur mustard toxicity and methods of using same
|
WO2006061992A1
(ja)
|
2004-12-10 |
2006-06-15 |
Ajinomoto Co., Inc. |
肝疾患予防・治療用組成物
|
US20080114067A1
(en)
|
2005-01-31 |
2008-05-15 |
Takanobu Yamamoto |
Composition for Recovery From or Prevention of Central Nervous System Fatigue
|
CA2537647A1
(en)
|
2005-03-01 |
2006-09-01 |
Six Star Formulations Ltd. |
Supplemental dietary composition for supporting muscle growth, recovery and strength
|
AU2006224792A1
(en)
|
2005-03-15 |
2006-09-21 |
Nestec S.A. |
Nutritional compositions for modulating Vitamin C bio-availability
|
KR20070112811A
(ko)
|
2005-03-21 |
2007-11-27 |
아보트 러보러터리즈 |
포도당내성을 개선시키기 위한 아미노산 조성물
|
EP1865944B1
(en)
|
2005-03-29 |
2018-08-29 |
Ajinomoto Co., Inc. |
Amino acid-containing composition used for preventing or remedying decrease in skeletal muscle mass of aged people, comprising L-leucine
|
EP2241195A1
(en)
|
2005-04-06 |
2010-10-20 |
Nestec S.A. |
A method and composition for nutritionally improving glucose control and insulin action
|
US8993627B2
(en)
|
2005-04-21 |
2015-03-31 |
Sentient Lifesciences, Inc. |
N-acetylcysteine amide (NAC amide) for the treatment of diseases and conditions associated with oxidative stress
|
EP1890688A2
(en)
|
2005-06-14 |
2008-02-27 |
Nestec S.A. |
Nutritional method
|
EP2184062A1
(en)
|
2005-06-22 |
2010-05-12 |
Ajinomoto Co., Inc. |
Use of glutamic acid and a nucleic acid as metabotropic glutamate receptor activators
|
US20100104548A1
(en)
|
2005-06-24 |
2010-04-29 |
Albert Einstein College Of Medicine Of Yeshiva University |
Modulation of amino acid metabolism in the hypothalamus
|
WO2007004613A1
(ja)
|
2005-07-01 |
2007-01-11 |
Ajinomoto Co., Inc. |
炎症性腸疾患治療薬及びTNF-α産生抑制剤
|
JP5682990B2
(ja)
|
2005-08-04 |
2015-03-11 |
味の素株式会社 |
酸化型アルブミン低下剤
|
WO2007018278A1
(ja)
|
2005-08-05 |
2007-02-15 |
Ajinomoto Co., Inc. |
肝癌発生・進展抑制剤
|
US8148356B2
(en)
|
2005-08-24 |
2012-04-03 |
Cumberland Pharmaceuticals, Inc. |
Acetylcysteine composition and uses therefor
|
EP1919304B1
(en)
|
2005-08-26 |
2011-05-25 |
Nestec S.A. |
Compositions and methods for improving functional vascular integrity, cellular survival and reducing apoptosis after an ischemic episode in the brain
|
EP1774973A1
(en)
|
2005-10-12 |
2007-04-18 |
Nutricia N.V. |
Leucine rich composition
|
EP2340725A1
(en)
|
2005-10-28 |
2011-07-06 |
Nestec S.A. |
Methods for the use of branched chain amino acids
|
WO2007056176A2
(en)
|
2005-11-03 |
2007-05-18 |
Southwest Immunology, Inc. |
Compositions for preventing and reducing delayed onset muscle soreness
|
WO2007056376A2
(en)
|
2005-11-07 |
2007-05-18 |
Perque, Llc. |
Compositions for regulating metabolic disorders and methods of use thereof
|
CA2631647A1
(en)
|
2005-11-30 |
2007-06-07 |
Nestec S.A. |
Use of branched-chain amino acids for the treatment of muscle loss
|
CN102225060A
(zh)
|
2005-12-19 |
2011-10-26 |
雅培制药有限公司 |
β-羟基-β-甲基丁酸盐在调节1-型和2-型细胞因子生成失衡中的应用
|
CA2631220A1
(en)
|
2006-01-09 |
2007-07-19 |
Nestec S.A. |
Treatment of stressed patients
|
ES2419229T3
(es)
|
2006-01-20 |
2013-08-20 |
Innova Food Ab |
Composición alimenticia que comprende aminoácidos
|
CA2637852A1
(en)
|
2006-01-31 |
2007-08-09 |
Nestec S.A. |
Nutritional composition for low birth weight infants
|
US20070270355A1
(en)
|
2006-05-11 |
2007-11-22 |
Garcia Ramon D |
Sport drink containing amino acids and carbohydrates
|
JP5100033B2
(ja)
|
2006-05-16 |
2012-12-19 |
大塚製薬株式会社 |
消化管及び腎臓の萎縮抑制剤
|
US20070286909A1
(en)
|
2006-06-07 |
2007-12-13 |
Daniel S. Smith |
Amino acid compositions
|
US9192593B2
(en)
|
2006-08-30 |
2015-11-24 |
Ajinomoto Co., Inc. |
Amino-acid containing composition for inhibiting accumulation of fat
|
CN101528066A
(zh)
|
2006-10-19 |
2009-09-09 |
雀巢产品技术援助有限公司 |
癌症患者的长期喂饲
|
US20080102137A1
(en)
|
2006-10-31 |
2008-05-01 |
Guffey Manning V R |
Composition and method for etiological treatment and prevention of diseases and/or complications associated with chronic glucose metabolism destabilization
|
GB0624879D0
(en)
|
2006-12-14 |
2007-01-24 |
Shs Int Ltd |
Treatment of pervasive development disorders
|
EP1932437A1
(en)
|
2006-12-15 |
2008-06-18 |
Nestec S.A. |
Infant formula
|
CN100518815C
(zh)
*
|
2007-02-15 |
2009-07-29 |
北京苏里曼医药科技有限公司 |
一种氨基酸组合物
|
US20080268038A1
(en)
|
2007-04-26 |
2008-10-30 |
Wolfe Robert R |
Compositions and Approaches for Increasing Diet Induced Thermogenesis, Inducing Weight Loss and Maintaining Muscle Mass and Strength
|
CN101332209B
(zh)
|
2007-06-25 |
2010-12-08 |
三菱制药(广州)有限公司 |
治疗肝性脑病的复方氨基酸注射液
|
US8466187B2
(en)
|
2007-09-18 |
2013-06-18 |
Thermolife International, Llc |
Amino acid compositions
|
US8455531B2
(en)
|
2007-09-18 |
2013-06-04 |
Thermolife International, Llc |
Amino acid compositions
|
KR100970664B1
(ko)
|
2007-10-11 |
2010-07-15 |
한화제약주식회사 |
L-오르니틴-l-아스파테이트를 함유한 겔제의 제조방법 및그 겔제
|
EP2057905A1
(en)
|
2007-11-12 |
2009-05-13 |
TIMA Foundation |
Composition for moderating Triglyceride and Cholesterol Levels
|
WO2009070378A1
(en)
|
2007-11-26 |
2009-06-04 |
Nestec S.A. |
Compositions and methods for inhibiting the activation of dsrna-dependent protein kinase and tumor growth inhibition
|
CN101214050B
(zh)
|
2007-12-28 |
2011-08-31 |
叶高山 |
一种具有提神、抗疲劳、醒酒功能的保健饮料
|
CA2709660C
(en)
|
2008-01-04 |
2018-06-05 |
Nestec S.A. |
Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing cognitive and related functions
|
US7790688B2
(en)
|
2008-01-11 |
2010-09-07 |
Healthspan Solutions, Llc |
Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly
|
US20090186098A1
(en)
|
2008-01-18 |
2009-07-23 |
Jose Briceno |
Sports drink composition
|
ATE523095T1
(de)
|
2008-01-25 |
2011-09-15 |
Cesar Gallia S R L |
Aminosäurenkonzentrat in wässrigem gel und mittels verdünnung besagten konzentrats mit wasser erhaltenes getränk zur bekämpfung von müdigkeit
|
US8716249B2
(en)
|
2008-01-31 |
2014-05-06 |
Energy Light Llc |
Compositions and methods for improving cardiovascular health
|
US20090203606A1
(en)
|
2008-02-05 |
2009-08-13 |
Wolfe Robert R |
Systems for and Methods of use of Therapeutic Nutrition for the Management of Age-Associated and Age-Specific Health Conditions of the Elderly
|
BRPI0908414A2
(pt)
|
2008-02-07 |
2015-08-04 |
Nestec Sa |
Composições e métodos para influenciar recuperação a partir de atividade física esforçada
|
EP2098126A1
(en)
|
2008-03-03 |
2009-09-09 |
Nestec S.A. |
Carbohydrate Bar
|
EP2098124A1
(en)
|
2008-03-03 |
2009-09-09 |
Nestec S.A. |
Carbohydrate gel
|
WO2009137827A2
(en)
|
2008-05-09 |
2009-11-12 |
Tiara Pharmaceuticals, Inc. |
Controlled release of n-acetylcysteine (nac) for reduction of systemic and/or vascular inflammation
|
WO2009149196A1
(en)
|
2008-06-04 |
2009-12-10 |
Phenolics, Llc. |
Enteric-coated formulations of polyethylene glycol and one or more soluble amino acids for oral ingestion and enhanced uptake of same
|
US20100021573A1
(en)
|
2008-07-22 |
2010-01-28 |
Michael J Gonzalez |
Compositions and methods for the prevention of cardiovascular disease
|
EP2165713B1
(en)
|
2008-09-19 |
2012-11-14 |
Nestec S.A. |
Whey and thymus function
|
CN102164595A
(zh)
|
2008-09-19 |
2011-08-24 |
雀巢产品技术援助有限公司 |
抗癌治疗中的免疫系统营养支持
|
EP2351562A4
(en)
|
2008-10-27 |
2012-09-05 |
Ajinomoto Kk |
SOLID SOLUTION OF VALIN, ISOLEUCIN AND LEUCIN AND MANUFACTURING PROCESS THEREFOR
|
US8362080B2
(en)
|
2008-12-18 |
2013-01-29 |
Baylor College Of Medicine |
Increasing glutathione levels for therapy
|
PL2376077T3
(pl)
|
2009-01-12 |
2017-10-31 |
Biokier Inc |
Kompozycja i sposób leczenia cukrzycy
|
US9314444B2
(en)
|
2009-01-12 |
2016-04-19 |
Biokier, Inc. |
Composition and method for treatment of NASH
|
US20120178672A1
(en)
|
2009-03-18 |
2012-07-12 |
Wolfe Robert R |
Compositions and Methods for Sparing Muscle in Renal Insufficiency and During Hemodialysis
|
WO2010108542A1
(en)
|
2009-03-25 |
2010-09-30 |
Nestec S.A. |
A natural taste enhancing savoury base and a process for its preparation
|
NO2413924T3
(es)
|
2009-04-03 |
2018-02-24 |
|
|
WO2010126353A1
(en)
|
2009-04-27 |
2010-11-04 |
N.V. Nutricia |
Pea-based protein mixture and use thereof in a liquid nutritional composition suitable for enteral feeding
|
US8703719B1
(en)
|
2009-05-18 |
2014-04-22 |
Bio-Engineered Supplements And Nutrition, Inc. |
Method and composition for improved muscle performance
|
BRPI1012956A8
(pt)
|
2009-06-08 |
2021-11-03 |
Ocera Therapeutics Inc |
Usos da l-ornitina e de pelo menos um de fenilacetato e fenilbutirato
|
WO2010143939A1
(en)
|
2009-06-09 |
2010-12-16 |
N.V. Nutricia |
Nutrition for improving muscle strength in elderly
|
EP2456448A1
(en)
|
2009-07-20 |
2012-05-30 |
Nestec S.A. |
Methods of attenuating the loss of functional status
|
WO2011030104A1
(en)
|
2009-09-09 |
2011-03-17 |
Rajiv Jalan |
Phenylacetate and/or phenylbutyrate (not ornithine) for reducing portal blood pressure
|
CN101664384B
(zh)
|
2009-09-18 |
2011-09-14 |
杭州市第六人民医院 |
N-乙酰半胱氨酸盐木糖醇注射液及其制备方法和应用
|
EP2480246A4
(en)
|
2009-09-23 |
2013-02-27 |
Biokier Inc |
COMPOSITION AND METHOD FOR THE TREATMENT OF DIABETES
|
WO2011044230A2
(en)
|
2009-10-06 |
2011-04-14 |
Goldstein Glenn A |
N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions
|
WO2011043647A1
(en)
|
2009-10-09 |
2011-04-14 |
N.V. Nutricia |
Amino acid composition with improved dispersibility
|
EP2327316B1
(en)
|
2009-11-29 |
2016-11-16 |
Premier Nutrition Corporation |
Method of enhancing muscle protein synthesis
|
EP2327315B1
(en)
|
2009-11-29 |
2013-10-09 |
Nestec S.A. |
Dosing protocols for increasing protein synthesis in an active individual
|
WO2011078654A1
(en)
|
2009-12-24 |
2011-06-30 |
N.V. Nutricia |
Low-caloric high-protein nutritional composition for the stimulation of muscle protein synthesis
|
JP2011132174A
(ja)
|
2009-12-24 |
2011-07-07 |
Kirin Holdings Co Ltd |
持久力向上剤
|
WO2011097273A1
(en)
|
2010-02-02 |
2011-08-11 |
Martek Biosciences Corporation |
Methods and compositions for treating non-alcoholic fatty liver disease with docosahexaenoic acid and n-acetyl lcystenine
|
MX2012010468A
(es)
|
2010-03-12 |
2012-10-03 |
Nestec Sa |
Composiciones para ocultar el sabor de nutrientes y metodos para producirlas.
|
WO2011119023A1
(en)
|
2010-03-26 |
2011-09-29 |
N.V. Nutricia |
Low protein infant formula with increased essential amino acids
|
CN103025178B
(zh)
|
2010-04-26 |
2015-02-11 |
雀巢产品技术援助有限公司 |
用于从胃肠外营养转换至肠内营养的营养组合物和方法
|
US8840950B2
(en)
|
2010-05-26 |
2014-09-23 |
Jacqueline M. Hibbert |
Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore
|
WO2012005568A1
(en)
|
2010-07-07 |
2012-01-12 |
N.V. Nutricia |
Nutritional composition for the stimulation of muscle protein synthesis
|
KR101213825B1
(ko)
|
2010-07-16 |
2012-12-18 |
서울대학교산학협력단 |
세린을 유효성분으로 함유하는 지방간 질환의 예방 및 치료용 조성물
|
MY173215A
(en)
|
2010-07-21 |
2020-01-06 |
Cumberland Pharmaceuticals Inc |
Acetylcysteine compositions and methods of use thereof
|
US20120020947A1
(en)
|
2010-07-22 |
2012-01-26 |
Northern Innovations And Formulations Corp. |
Compositions and methods for increasing lean muscle mass after exercise
|
CN101912394B
(zh)
|
2010-08-06 |
2013-11-06 |
岳茂兴 |
一种用于治疗凝血障碍出血的药物组合物及其用途
|
JP6087284B2
(ja)
|
2010-10-06 |
2017-03-01 |
オセラ セラピューティクス, インコーポレイテッド |
L−オルニチンフェニルアセテートを製造するための方法
|
EP2444083A1
(en)
|
2010-10-21 |
2012-04-25 |
Nestec S.A. |
Cysteine and food intake
|
SG191315A1
(en)
|
2010-12-22 |
2013-07-31 |
Abbott Lab |
Nutritional products comprising calcium beta-hydroxy-beta methylbutyrate and conjugated linoleic acid
|
CA2821312A1
(en)
|
2010-12-27 |
2012-07-05 |
Abbott Laboratories |
Methods for facilitating muscle recovery after a period of disuse using beta-hydroxy-beta-methylbutyrate
|
WO2012097061A1
(en)
|
2011-01-13 |
2012-07-19 |
Abbott Laboratories |
Nutritional compositions and methods for improving skeletal muscle protein metabolism
|
CA2825022A1
(en)
|
2011-01-25 |
2012-08-02 |
Nestec S.A. |
Methods and compositions for treating, reducing, or preventing deterioration of the visual system of animals
|
RU2491062C2
(ru)
|
2011-03-16 |
2013-08-27 |
Общество С Ограниченной Ответственностью "Биотехнологии Пущино" |
Композиции протекторов острых и хронических печеночных энцелопатий и способ лечения острых и хронических печеночных энцелопатий
|
ES2727043T3
(es)
|
2011-03-18 |
2019-10-11 |
Nestle Sa |
Composiciones y métodos útiles para mejorar enfermedades relacionadas con la edad
|
WO2012135499A1
(en)
|
2011-03-31 |
2012-10-04 |
Ganeden Biotech, Inc. |
Probiotic sports nutrition compositions
|
CN102327259A
(zh)
|
2011-03-31 |
2012-01-25 |
姜国辉 |
具有显著化学性肝损伤保护功能的复合生物制剂
|
CA2831341A1
(en)
|
2011-04-12 |
2012-10-18 |
Nestec S.A. |
Nutritional compositions including branched chain fatty acids for wound healing
|
EP2699113A1
(en)
|
2011-04-18 |
2014-02-26 |
Nestec S.A. |
Nutritional compositions having alpha-hica and eicosapentaenoic acid
|
US20120270860A1
(en)
|
2011-04-19 |
2012-10-25 |
Gihyun Yoon |
Methods for treating or preventing alcohol-related disorders or craving-related disorders
|
SG193967A1
(en)
|
2011-04-21 |
2013-11-29 |
Nestec Sa |
Nutritional compositions for enhancing performance and methods for making and using same
|
US8828426B2
(en)
|
2011-06-07 |
2014-09-09 |
Zx Pharma, Llc |
Multiparticulate L-carnitine compositions and related methods
|
US20140135396A1
(en)
|
2011-07-05 |
2014-05-15 |
Beth Israel Deaconess Medical Center, Inc. |
Treatment of Acetaminophen-Induced Liver Damage by the Administration of Modulators of Nitric Oxide
|
EP2742938B1
(en)
|
2011-08-08 |
2018-05-09 |
Ajinomoto Co., Inc. |
Amino-acid-containing composition for enhancing recovery from muscle fatigue
|
EP2744356A4
(en)
|
2011-08-19 |
2015-05-27 |
Musclepharm Corp |
COMPOSITIONS AND METHODS FOR INHIBITING INCOUNTERANCE IN ANIMALS
|
EP2574333B1
(en)
|
2011-09-27 |
2017-01-11 |
Friulchem SpA |
N-acetylcysteine effervescent tablet and its therapeutical applications
|
EP2580967A1
(en)
|
2011-10-11 |
2013-04-17 |
Nestec S.A. |
Accelerating muscle recovery after immobilization-induced muscle atrophy
|
EP2583565A1
(en)
|
2011-10-21 |
2013-04-24 |
Nestec S.A. |
Use of whey protein micelles for enhancing energy expenditure and satiety
|
EP2583563A1
(en)
|
2011-10-21 |
2013-04-24 |
Nestec S.A. |
Whey protein micelles against muscle atrophy and sarcopenia
|
US9364463B2
(en)
*
|
2011-11-18 |
2016-06-14 |
Board Of Trustees Of The University Of Arkansas |
Use of amino acid supplementation for improved muscle recovery
|
ES2785094T3
(es)
|
2011-11-21 |
2020-10-05 |
Emmaus Medical Inc |
Métodos y composiciones para el tratamiento de la diabetes y los síntomas relacionados
|
EP2786750B2
(en)
|
2011-12-02 |
2023-06-28 |
EA Pharma Co., Ltd. |
Agent for reducing adverse side effects of kinase inhibitor
|
EP2805617A4
(en)
|
2012-01-19 |
2015-08-12 |
Shoichi Shirotake |
ANTIBACTERIAL AGENT AGAINST BACTERIA CAUSING PLANT DISEASE
|
US9198454B2
(en)
|
2012-03-08 |
2015-12-01 |
Nusirt Sciences, Inc. |
Compositions, methods, and kits for regulating energy metabolism
|
WO2013188258A1
(en)
|
2012-06-11 |
2013-12-19 |
Abbott Laboratories |
Use of hmb to improve health outcomes for hospitalized patients
|
AU2013298645B2
(en)
|
2012-07-31 |
2016-11-03 |
Société des Produits Nestlé S.A. |
Nutritional composition for promoting musculoskeletal health in patients with inflammatory bowel disease (IBD)
|
US20150223501A1
(en)
|
2012-09-14 |
2015-08-13 |
Nestec S.A. |
Novel flavour compositions with improved flavour and/or flavour shelf-life
|
US8747921B2
(en)
|
2012-09-19 |
2014-06-10 |
Quality Ip Holdings, Inc. |
Methods for improving health in humans
|
US9198889B2
(en)
|
2012-09-19 |
2015-12-01 |
Quality IP Holdings, LLC |
Methods for treating post-traumatic stress disorder
|
US9066953B2
(en)
|
2012-09-20 |
2015-06-30 |
Quality IP Holdings, LLC |
Methods for increasing endurance and fat metabolism in humans
|
CN102961377A
(zh)
|
2012-11-08 |
2013-03-13 |
湖北一半天制药有限公司 |
复方氨基酸注射液(20aa)的制备方法
|
US9410963B2
(en)
|
2012-12-04 |
2016-08-09 |
Nestec S.A. |
Hexanoylglycine as biomarker for the predisposition for weight gain and obesity
|
BR112015018625A2
(pt)
|
2013-02-04 |
2017-09-19 |
Seres Therapeutics Inc |
composições e métodos
|
KR102060292B1
(ko)
|
2013-03-11 |
2019-12-27 |
유니버시티 오브 플로리다 리서치 파운데이션, 인크. |
폐 기능의 개선 및 방사선 유발된 폐 합병증의 예방 및/또는 치료를 위한 물질 및 방법
|
SG11201507046UA
(en)
|
2013-03-15 |
2015-10-29 |
Nusirt Sciences Inc |
Leucine and nicotinic acid reduces lipid levels
|
AU2014242565A1
(en)
|
2013-03-26 |
2015-10-15 |
Premier Nutrition Corporation |
Methods for enhancing muscle protein synthesis following concurrent training
|
DK2986156T3
(en)
|
2013-04-15 |
2017-02-20 |
Nestec Sa |
USE OF WHEEL PROTEIN IN COMBINATION WITH ELECTRICAL MUSCLE STIMULATION
|
CA2912519A1
(en)
|
2013-04-16 |
2014-10-23 |
The Children's Hospital Of Philadelphia |
Compositions and methods for the treatment of brain injury
|
US20140357576A1
(en)
|
2013-05-31 |
2014-12-04 |
Nestec S.A. |
Methods for enhancement of muscle protein synthesis
|
BR112015032572B1
(pt)
|
2013-06-28 |
2021-04-13 |
Société des Produits Nestlé S.A. |
Suplemento pré-exercício para cães
|
WO2015015149A1
(en)
|
2013-07-31 |
2015-02-05 |
Leeds Metropolitan University |
Dietary supplement
|
US20180125926A1
(en)
|
2013-09-25 |
2018-05-10 |
Axcella Health Inc. |
Compositions and Formulations and Methods of Production and Use Thereof
|
WO2015048334A2
(en)
|
2013-09-25 |
2015-04-02 |
Pronutria, Inc. |
Edible species nutritive polypeptides and methods of production and use thereof
|
US9913818B2
(en)
|
2013-10-09 |
2018-03-13 |
Nestec S.A. |
Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome
|
US20170027897A1
(en)
|
2013-10-23 |
2017-02-02 |
Whitehead Institute For Biomedical Research |
mTORC1 MODULATION BY AMINO ACIDS AND USES THEREOF
|
MX2016011063A
(es)
|
2014-02-27 |
2016-11-30 |
Nusirt Sciences Inc |
Composiciones y metodos para la reduccion o prevencion de esteatosis hepatica.
|
GB2523578A
(en)
|
2014-02-28 |
2015-09-02 |
Daniel Nelson |
A nutritional supplement
|
WO2015161448A1
(en)
|
2014-04-22 |
2015-10-29 |
Wuhan Ll Science And Technology Development Co., Ltd. |
Ornithine-containing or aspartate-containing compositions and the uses thereof
|
CN105092753B
(zh)
|
2014-05-20 |
2016-09-07 |
中国科学院大连化学物理研究所 |
组合型胺类代谢标志物的应用及试剂盒
|
WO2016003263A1
(en)
|
2014-07-01 |
2016-01-07 |
N.V. Nutricia |
Amino acid based diet with improved taste
|
US10217645B2
(en)
|
2014-07-25 |
2019-02-26 |
Versum Materials Us, Llc |
Chemical mechanical polishing (CMP) of cobalt-containing substrate
|
US20160158305A1
(en)
|
2014-09-19 |
2016-06-09 |
Chip E. Thomson |
Additives and supplements
|
WO2016058919A1
(en)
|
2014-10-14 |
2016-04-21 |
Nestec S.A. |
Improvement in muscle functionality of elderly males
|
CN107206021B
(zh)
|
2014-11-24 |
2021-09-03 |
Ucl商业有限公司 |
使用降氨疗法治疗与肝星状细胞激活相关的疾病
|
RS60268B1
(sr)
|
2014-12-04 |
2020-06-30 |
Professional Dietetics Int S R L In Forma Abbreviata P D Int S R L |
Aminokiselinska struktura za obnovu fibroelastina u dermalnim vezujućim tkivima
|
WO2016094316A1
(en)
|
2014-12-08 |
2016-06-16 |
Synaptamine, Inc. |
Anti-rds compounds and method of manufacture and administration thereof to induce dopamine homeostatis
|
EP3034074A1
(en)
|
2014-12-18 |
2016-06-22 |
Universitat De València, Estudi General |
Compound for treatment of myotonic dystrophy type 1
|
AU2016208545A1
(en)
|
2015-01-23 |
2017-06-15 |
Société des Produits Nestlé S.A. |
Treatment or prevention of inflammation using serine
|
ES2946666T3
(es)
|
2015-01-23 |
2023-07-24 |
Nestle Sa |
Método para determinar los requerimientos nutricionales distintivos de un paciente
|
CA2973413A1
(en)
|
2015-01-23 |
2016-07-28 |
Nestec S.A. |
Promotion of healing of intestinal mucosa using proline, serine and threonine
|
EP3247343A1
(en)
|
2015-01-23 |
2017-11-29 |
Nestec S.A. |
Nutritional composition useful in the treatment of ibd patients
|
JP6847668B2
(ja)
|
2015-01-27 |
2021-03-24 |
昇一 城武 |
ナノ粒子を有効成分とする皮膚炎の治療又は予防剤
|
JP2018510129A
(ja)
|
2015-02-13 |
2018-04-12 |
ネステク ソシエテ アノニム |
手術によって誘発される悪液質並びに/又は骨髄由来サプレッサー細胞及び炎症性サイトカインの発現の処置又は予防
|
US20180036270A1
(en)
|
2015-02-13 |
2018-02-08 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
A method of protecting against carbonyl stress induced ischemia-reperfusion injury in the diabetic brain via administration of n-acetylcysteine
|
FR3032883B1
(fr)
|
2015-02-24 |
2017-03-17 |
International Nutrition Res Company |
Composition pour la prevention et le traitement de la steatose et de la steatohepatite metaboliques
|
US20160302451A1
(en)
|
2015-04-16 |
2016-10-20 |
Michael Hudnall |
Medical Food for Patients with Chronic Liver Disease
|
MX2017013170A
(es)
|
2015-04-20 |
2018-04-11 |
Ocera Therapeutics Inc |
Formulaciones de fenilacetato de l-ornitina.
|
US10123985B2
(en)
|
2015-06-08 |
2018-11-13 |
Whitehead Institute For Biomedical Research |
Therapeutic strategies for treating mitochondrial disorders
|
ES2860427T3
(es)
|
2015-06-22 |
2021-10-05 |
Nestle Sa |
Composiciones y métodos para mejorar la neurogénesis en animales
|
ES2809482T3
(es)
|
2015-06-30 |
2021-03-04 |
Nestle Sa |
Composición adecuada para proteger microorganismos
|
WO2017011471A1
(en)
|
2015-07-15 |
2017-01-19 |
Unigen, Inc. |
Compositions, methods, and medical compositions for treatment of and maintaining the health of the liver
|
RU2723947C2
(ru)
|
2015-08-14 |
2020-06-18 |
Сосьете Де Продюи Нестле С.А. |
Полувлажные композиции корма, которые сохраняют мягкую текстуру
|
AU2016308641B2
(en)
|
2015-08-18 |
2022-02-03 |
Ocera Therapeutics, Inc. |
Treatment and prevention of muscle loss using L-ornithine in combination with at least one of phenylacetate and phenylbutyrate
|
WO2017033272A1
(ja)
|
2015-08-25 |
2017-03-02 |
昇一 城武 |
優れた植物病害防除効果を有する菌類用抗菌剤
|
US20170079897A1
(en)
|
2015-09-20 |
2017-03-23 |
Matthew Brissette MINUS |
Composition for hair application and methods of hair care
|
WO2017053613A1
(en)
|
2015-09-25 |
2017-03-30 |
Ocera Therapeutics, Inc. |
Treatment and prevention of neuronal cell loss using l-ornithine in combination with at least one of phenylacetate and phenylbutyrate
|
US20170196944A1
(en)
*
|
2015-09-28 |
2017-07-13 |
Robert Portman |
Method to reduce muscle atrophy following orthopedic surgery
|
CN108366983A
(zh)
|
2015-11-13 |
2018-08-03 |
欧塞拉治疗有限公司 |
L-鸟氨酸苯乙酸盐制剂
|
US11219611B2
(en)
|
2015-11-13 |
2022-01-11 |
Ocera Therapeutics, Inc. |
Formulations of L-ornithine phenylacetate
|
CN108348553A
(zh)
|
2015-11-20 |
2018-07-31 |
雀巢产品技术援助有限公司 |
使用乳清蛋白以改善或维持肌肉质量的方法
|
ES2699722B1
(es)
|
2015-12-21 |
2020-01-02 |
Nanjing Jianrong Bio Tech Co Ltd |
Composicion para tratar enfermedades de las neuronas motoras y uso de la misma
|
EA201891592A1
(ru)
|
2016-01-08 |
2019-02-28 |
КОЛОНАРИКОНСЕПТС ЭлЭлСи |
Основанная на пищевых продуктах доставка терапевтического агента для лечения печеночной энцефалопатии
|
GB201600990D0
(en)
|
2016-01-19 |
2016-03-02 |
Abbott Lab |
Pharmaceutical or nutritional combination
|
US20190133147A1
(en)
|
2016-05-11 |
2019-05-09 |
Tsubo Solutions Pty Ltd |
Confectionery product
|
JP2019518744A
(ja)
|
2016-05-27 |
2019-07-04 |
ネステク ソシエテ アノニム |
運動障害を治療又は予防するための栄養組成物
|
PL238958B1
(pl)
|
2016-06-29 |
2021-10-25 |
Olimp Laboratories Spolka Z Ograniczona Odpowiedzialnoscia |
Kompozycja aminokwasowa do stosowania przed wysiłkiem fizycznym
|
US20180015122A1
(en)
|
2016-07-14 |
2018-01-18 |
Companion Supplements, LLC |
Pharmaceutical composition effective in preventing adverse effects associated with the use of glucocorticoids
|
JOP20190146A1
(ar)
|
2016-12-19 |
2019-06-18 |
Axcella Health Inc |
تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
|
JOP20190147A1
(ar)
|
2016-12-19 |
2019-06-18 |
Axcella Health Inc |
تركيبات حمض أميني وطرق لمعالجة أمراض واضطرابات العضلات
|
CN106632605B
(zh)
|
2016-12-22 |
2020-06-16 |
浙江海洋大学 |
利用金枪鱼下脚料制备的具有肝损伤修复作用的活性肽
|
SE540582C2
(en)
|
2016-12-22 |
2018-10-02 |
Scandibio Therapeutics Ab |
Substances for treatment of fatty liver-related conditions
|
EP3570826A4
(en)
|
2017-01-19 |
2020-09-23 |
Otologic Pharmaceutics, Inc. |
N-ACETYLCYSTEIN FORMULATIONS AND THEIR USES
|
EP3615018A1
(en)
|
2017-04-28 |
2020-03-04 |
Axcella Health Inc. |
Amino acid compositions and their use for the treatment of traumatic brain injury
|
CN107242552A
(zh)
|
2017-07-07 |
2017-10-13 |
上海东锦食品集团有限公司 |
具有缓解体力疲劳及增强免疫力功能的保健食品组合物
|
CN111295187A
(zh)
|
2017-08-14 |
2020-06-16 |
胺细拉健康公司 |
用于治疗肝脏疾病的氨基酸组合物
|
KR20200040276A
(ko)
|
2017-08-14 |
2020-04-17 |
악셀라 헬스 인크. |
신경 손상 치료를 위한 아미노산 조성물
|
CN108041501A
(zh)
|
2017-12-22 |
2018-05-18 |
北京康比特体育科技股份有限公司 |
一种促进疲劳恢复的蛋白组合物及其制备方法
|
US20190388377A1
(en)
|
2018-06-20 |
2019-12-26 |
Axcella Health Inc. |
Compositions and methods for the treatment of liver diseases and disorders
|
CU20200106A7
(es)
|
2018-06-20 |
2021-08-06 |
Axcella Health Inc |
Composiciones y métodos para el tratamiento de hemoglobinopatías y talasemias
|
US11679089B2
(en)
|
2018-06-20 |
2023-06-20 |
Axcella Health Inc. |
Methods of manufacturing amino acid compositions
|
MX2020013731A
(es)
|
2018-06-20 |
2021-02-26 |
Axcella Health Inc |
Composiciones para terapia y salud que contienen aminoacidos con sabor amargo.
|
CN112839643A
(zh)
|
2018-06-20 |
2021-05-25 |
胺细拉健康公司 |
用于治疗肌肉中脂肪浸润的组合物及方法
|
CN108524453A
(zh)
|
2018-07-05 |
2018-09-14 |
扬子江药业集团广州海瑞药业有限公司 |
一种门冬氨酸鸟氨酸的药物组合物
|